Board of Directors
The N2 Board of Directors consists of 12 individuals representing the different stakeholders within N2 membership.
Executive Director Canadian Cancer Clinical Trials Network (3CTN)
Vice President, Clinical Operations & Drug Development-Qu Biologics Inc.
Assistant Director, Institute of Cancer Research, CIHR
N2 Board Member
Chief Research Officer Centre for Health Evaluation & Outcome Sciences (CHÉOS), CIHR Canadian HIV Trials Network (CTN)
Project Manager, Marvelle Koffler Breast Centre Research Program
Executive Director C-17 Council
Clinical Research Facilitator, Ottawa Hospital Research Institute (OHRI)
Director, Platform Operations – Alberta Innovates – Health Solutions
Chief Operating Officer of the Population Health Research Institute, A Joint Institute of HHS and McMaster University